Cargando…
Modulation of the Blood–Brain Barrier for Drug Delivery to Brain
The blood–brain barrier (BBB) precisely controls brain microenvironment and neural activity by regulating substance transport into and out of the brain. However, it severely hinders drug entry into the brain, and the efficiency of various systemic therapies against brain diseases. Modulation of the...
Autor principal: | Han, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708282/ https://www.ncbi.nlm.nih.gov/pubmed/34959306 http://dx.doi.org/10.3390/pharmaceutics13122024 |
Ejemplares similares
-
Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
por: Luo, Huilong, et al.
Publicado: (2020) -
Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies
por: Han, Liang, et al.
Publicado: (2021) -
The blood–brain barrier: structure, regulation, and drug delivery
por: Wu, Di, et al.
Publicado: (2023) -
Nanoscale drug delivery systems and the blood–brain barrier
por: Alyautdin, Renad, et al.
Publicado: (2014) -
Peptide Shuttles for Blood–Brain Barrier Drug Delivery
por: Sánchez-Navarro, Macarena, et al.
Publicado: (2022)